Ginkgo Bioworks Holdings annual book value per share
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Book Value Per Share Growth & History (DNA)
Ginkgo Bioworks Holdings's book value per share was $8.74 for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.74 | -$4.43 | −33.66% |
| 2024 | 2024-12-31 | $13.17 | -$8.76 | −39.94% |
| 2023 | 2023-12-31 | $21.93 | -$1,446.40 | −98.51% |
| 2022 | 2022-12-31 | $1,468.33 | -$26.39 | −1.77% |
| 2021 | 2021-12-31 | $1,494.72 | $1,494.70 | +6018941.14% |
| 2020 | 2020-12-31 | $0.02 | -$698.81 | −100.00% |
| 2019 | 2019-12-31 | $698.84 | — | — |
Ginkgo Bioworks Holdings quarterly book value per share
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.60 | -$4.46 | −40.35% |
| Q1 2026 | 2026-03-31 | $7.19 | -$4.65 | −39.28% |
| Q4 2025 | 2025-12-31 | $8.74 | -$4.43 | −33.66% |
| Q3 2025 | 2025-09-30 | $9.85 | -$5.18 | −34.48% |
| Q2 2025 | 2025-06-30 | $11.06 | -$630.15 | −98.28% |
| Q1 2025 | 2025-03-31 | $11.84 | -$764.92 | −98.48% |
| Q4 2024 | 2024-12-31 | $13.17 | -$8.76 | −39.94% |
| Q3 2024 | 2024-09-30 | $15.03 | -$1,000.97 | −98.52% |
| Q2 2024 | 2024-06-30 | $641.21 | -$589.53 | −47.90% |
| Q1 2024 | 2024-03-31 | $776.76 | -$553.28 | −41.60% |
| Q4 2023 | 2023-12-31 | $21.93 | -$1,446.40 | −98.51% |
| Q3 2023 | 2023-09-30 | $1,016.00 | -$376.72 | −27.05% |
| Q2 2023 | 2023-06-30 | $1,230.74 | -$271.24 | −18.06% |
| Q1 2023 | 2023-03-31 | $1,330.04 | -$229.26 | −14.70% |
| Q4 2022 | 2022-12-31 | $1,468.33 | -$26.39 | −1.77% |
| Q3 2022 | 2022-09-30 | $1,392.73 | -$277.05 | −16.59% |
| Q2 2022 | 2022-06-30 | $1,501.98 | $1,495.79 | +24167.04% |
| Q1 2022 | 2022-03-31 | $1,559.30 | $1,553.10 | +25049.24% |
| Q4 2021 | 2021-12-31 | $1,494.72 | $1,494.70 | +6018941.14% |
| Q3 2021 | 2021-09-30 | $1,669.78 | — | — |
| Q2 2021 | 2021-06-30 | $6.19 | — | — |
| Q1 2021 | 2021-03-31 | $6.20 | — | — |
| Q4 2020 | 2020-12-31 | $0.02 | — | — |
Ginkgo Bioworks Holdings book value per share trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's book value per share increased from $0.02 to $8.74, a change of $8.71. The latest reported quarter, Q2 2026, shows $6.60.
About the metric
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
Calculation and source
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo links laboratory data services with Lilly’s TuneLab platform
Ginkgo ($DNA) Bioworks entered an agreement to provide experimental data-generation services to companies using Lilly’s ($LLY) TuneLab AI drug-discovery platform. Its Datapoints offering will supply small-molecule and antibody developabilit ...
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...
